FR2759908B1 - Nouvelle composition pour inhalation - Google Patents

Nouvelle composition pour inhalation

Info

Publication number
FR2759908B1
FR2759908B1 FR9800458A FR9800458A FR2759908B1 FR 2759908 B1 FR2759908 B1 FR 2759908B1 FR 9800458 A FR9800458 A FR 9800458A FR 9800458 A FR9800458 A FR 9800458A FR 2759908 B1 FR2759908 B1 FR 2759908B1
Authority
FR
France
Prior art keywords
inhalation
new composition
budesonide
formulation
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9800458A
Other languages
English (en)
Other versions
FR2759908A1 (fr
Inventor
Jan Trofast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2759908(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Publication of FR2759908A1 publication Critical patent/FR2759908A1/fr
Application granted granted Critical
Publication of FR2759908B1 publication Critical patent/FR2759908B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9800458A 1997-01-20 1998-01-16 Nouvelle composition pour inhalation Expired - Lifetime FR2759908B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700133A SE9700133D0 (sv) 1997-01-20 1997-01-20 New formulation

Publications (2)

Publication Number Publication Date
FR2759908A1 FR2759908A1 (fr) 1998-08-28
FR2759908B1 true FR2759908B1 (fr) 2000-04-21

Family

ID=20405452

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9800458A Expired - Lifetime FR2759908B1 (fr) 1997-01-20 1998-01-16 Nouvelle composition pour inhalation

Country Status (35)

Country Link
US (1) US6027714A (fr)
EP (1) EP1019033B1 (fr)
JP (1) JP2010059179A (fr)
KR (1) KR100528418B1 (fr)
CN (1) CN1222282C (fr)
AT (1) ATE389390T1 (fr)
AU (1) AU726916B2 (fr)
BE (1) BE1011400A5 (fr)
BR (1) BR9806892A (fr)
CA (1) CA2277914C (fr)
CZ (1) CZ295083B6 (fr)
DE (1) DE69839275T2 (fr)
DK (1) DK1019033T3 (fr)
EE (1) EE03998B1 (fr)
ES (2) ES2302348T3 (fr)
FR (1) FR2759908B1 (fr)
GR (1) GR1003290B (fr)
HK (1) HK1025516A1 (fr)
HU (1) HU228312B1 (fr)
ID (1) ID22883A (fr)
IE (1) IE980024A1 (fr)
IL (1) IL130840A (fr)
IS (1) IS2563B (fr)
NL (1) NL1008019C2 (fr)
NO (1) NO327451B1 (fr)
NZ (1) NZ336592A (fr)
PL (1) PL191569B1 (fr)
PT (1) PT1019033E (fr)
RU (1) RU2180563C2 (fr)
SE (1) SE9700133D0 (fr)
SI (1) SI1019033T1 (fr)
SK (1) SK283948B6 (fr)
TR (1) TR199901691T2 (fr)
UA (1) UA57762C2 (fr)
WO (1) WO1998031350A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
EP1129705A1 (fr) 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Formulation en poudre pour inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
FR2809692A1 (fr) 2000-05-31 2001-12-07 Ecia Equip Composants Ind Auto Ensemble de masquage d'un coussin gonflable de securite pour vehicule automobile, procede de fabrication et planche de bord correspondante
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
SE0200657D0 (sv) * 2002-03-04 2002-03-04 Astrazeneca Ab Novel Formulation
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
WO2011110852A1 (fr) 2010-03-10 2011-09-15 Astrazeneca Ab Formes polymorphes de l'éthylamide de l'acide 6-[2-(4-cyanophényl)-2h-pyrazol-3-yl]-5-méthyl-3-oxo-4-(trifluorométhylphényl)-3,4-dihydropyrazine-2-carboxylique
PL2821061T3 (pl) 2013-07-01 2018-05-30 Arven Ilac Sanayi Ve Ticaret A.S. Nowe preparaty do inhalacji
EP3668505A4 (fr) 2017-08-15 2021-05-12 Nephron Pharmaceuticals Corporation Composition de nébulisation aqueuse
CA3150240A1 (fr) 2019-09-24 2021-04-01 Tomaso GUIDI Formulation de poudre seche pour un inhalateur a poudre seche comprenantune combinaison de particules spheronisees et de particules grossieres, et inhalateur a poudre seche comprenant la formulation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
SE438261B (sv) * 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
ATE23272T1 (de) * 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
EP0072046B1 (fr) * 1981-07-24 1986-01-15 FISONS plc Médicaments pour inhalation, méthodes pour leur production et formulations pharmaceutiques les contenant
DE69034007T2 (de) * 1989-04-28 2003-05-08 Riker Laboratories Inc., Northridge Inhalationsvorrichtung für Trockenpulver
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
ES2200771T3 (es) * 1991-06-10 2004-03-16 Schering Corporation Formulaciones en aerosol no clorofluorocarbonadas.
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
HU0004452D0 (fr) * 1991-12-18 2001-01-29 Astra Ab
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
EP0665010B1 (fr) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Procede pour fabriquer des matrices de cire
IS1736B (is) * 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
DE69429357T2 (de) * 1993-10-01 2002-08-14 Astrazeneca Ab, Soedertaelje Verfahren i
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
AU701440B2 (en) * 1994-09-29 1999-01-28 Quadrant Drug Delivery Limited Spray-dried microparticles as therapeutic vehicles
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
RU2071317C1 (ru) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Лекарственный порошкообразный препарат для ингаляций
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
HUP0000841A3 (en) 2001-01-29
ID22883A (id) 1999-12-16
ES2302348T3 (es) 2008-07-01
HK1025516A1 (en) 2000-11-17
ES2148059B1 (es) 2001-04-01
NL1008019A1 (nl) 1998-07-22
NO327451B1 (no) 2009-07-06
NO993537L (no) 1999-09-17
TR199901691T2 (xx) 1999-09-21
SE9700133D0 (sv) 1997-01-20
CA2277914C (fr) 2006-08-29
CN1222282C (zh) 2005-10-12
BE1011400A5 (fr) 1999-08-03
HUP0000841A2 (hu) 2000-10-28
EE9900320A (et) 2000-02-15
UA57762C2 (uk) 2003-07-15
NO993537D0 (no) 1999-07-19
US6027714A (en) 2000-02-22
PL334493A1 (en) 2000-02-28
SK95799A3 (en) 2000-01-18
ATE389390T1 (de) 2008-04-15
CZ295083B6 (cs) 2005-05-18
DE69839275T2 (de) 2009-04-02
GR980100021A (el) 1998-09-30
PT1019033E (pt) 2008-05-13
AU726916B2 (en) 2000-11-23
EE03998B1 (et) 2003-04-15
DE69839275D1 (de) 2008-04-30
IL130840A (en) 2005-03-20
RU2180563C2 (ru) 2002-03-20
DK1019033T3 (da) 2008-06-09
NL1008019C2 (nl) 1998-12-16
WO1998031350A1 (fr) 1998-07-23
EP1019033A1 (fr) 2000-07-19
ES2148059A1 (es) 2000-10-01
IE980024A1 (en) 1998-10-07
PL191569B1 (pl) 2006-06-30
NZ336592A (en) 2001-01-26
JP4512202B2 (ja) 2010-07-28
CA2277914A1 (fr) 1998-07-23
CZ255599A3 (cs) 1999-10-13
HU228312B1 (en) 2013-03-28
JP2001509811A (ja) 2001-07-24
IS2563B (is) 2009-12-15
SK283948B6 (sk) 2004-05-04
EP1019033B1 (fr) 2008-03-19
KR20000070186A (ko) 2000-11-25
FR2759908A1 (fr) 1998-08-28
JP2010059179A (ja) 2010-03-18
KR100528418B1 (ko) 2005-11-16
GR1003290B (el) 2000-01-03
SI1019033T1 (sl) 2008-08-31
AU5785798A (en) 1998-08-07
IS5110A (is) 1999-07-06
IL130840A0 (en) 2001-01-28
BR9806892A (pt) 2000-05-16
CN1243434A (zh) 2000-02-02

Similar Documents

Publication Publication Date Title
MY132999A (en) New formulation for inhalation
FR2759908B1 (fr) Nouvelle composition pour inhalation
FR2759907B1 (fr) Nouvelle composition pour inhalation
FR2759905B1 (fr) Nouvelle composition pour inhalation

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20